RAG1 and colitis: To more specifically address the activity of Treg once inflammatory pathology was established, we chose the curative model of T cell transfer colitis, whereby Treg are injected into RAG1−/− after disease onset (38), and control of colonic inflammation can only occur if Treg migrate to the site of inflammation.